open access

Vol 80, No 1 (2009)
ARTICLES
Get Citation

The influence of a combined low dose oral contraceptive containing drospirenone on electrolite equlibrum and renal function in young woman

Katarzyna Skórzewska, Stanisław Radowicki, Katarzyna Szlendak-Sauer
Ginekol Pol 2009;80(1).

open access

Vol 80, No 1 (2009)
ARTICLES

Abstract

Abstract Drospirenone – a new 17α-spironolactone derivate is a progestin with aldosterone receptor antagonism activity (PARA) thanks to which it decreases sodium and fluid retention. The aim: The aim of our study was to estimate the electrolytes level and renal function parameters in blood during the therapy of low dose oral contraceptive containing drospirenone. Material and methods: The group consisted of 22 young women in mean age 25,9+/-4,3 years, without contraindications to hormonal contraception used specimen containing 20μg ethinyloestradiol and 3.0mg drospirenone during 12 cycles. Blood levels of electrolytes (sodium, potassium, calcium, phosphorus and chloride) and renal function parameters (creatinine, urea and uric acid) were evaluated before and after 3, 6 and 12 cycles of the treatment. Results: There were no statistically significant differences observed in serum concentration of electrolytes and renal function parameters. Conclusion: The therapy of a low dose oral contraceptive containing 20μg ethinyloestradiol and 3.0mg drospirenone does not influence the electrolyte equilibrium and renal function.

Abstract

Abstract Drospirenone – a new 17α-spironolactone derivate is a progestin with aldosterone receptor antagonism activity (PARA) thanks to which it decreases sodium and fluid retention. The aim: The aim of our study was to estimate the electrolytes level and renal function parameters in blood during the therapy of low dose oral contraceptive containing drospirenone. Material and methods: The group consisted of 22 young women in mean age 25,9+/-4,3 years, without contraindications to hormonal contraception used specimen containing 20μg ethinyloestradiol and 3.0mg drospirenone during 12 cycles. Blood levels of electrolytes (sodium, potassium, calcium, phosphorus and chloride) and renal function parameters (creatinine, urea and uric acid) were evaluated before and after 3, 6 and 12 cycles of the treatment. Results: There were no statistically significant differences observed in serum concentration of electrolytes and renal function parameters. Conclusion: The therapy of a low dose oral contraceptive containing 20μg ethinyloestradiol and 3.0mg drospirenone does not influence the electrolyte equilibrium and renal function.
Get Citation

Keywords

contraception, drospirenone, Electrolytes, renal function

About this article
Title

The influence of a combined low dose oral contraceptive containing drospirenone on electrolite equlibrum and renal function in young woman

Journal

Ginekologia Polska

Issue

Vol 80, No 1 (2009)

Bibliographic record

Ginekol Pol 2009;80(1).

Keywords

contraception
drospirenone
Electrolytes
renal function

Authors

Katarzyna Skórzewska
Stanisław Radowicki
Katarzyna Szlendak-Sauer

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl